General Information of Drug Transporter (DT)
DT ID DTD0534 Transporter Info
Gene Name CACNA1C
Transporter Name Voltage-gated calcium channel alpha Cav1.2
Gene ID
775
UniProt ID
Q13936
Post-Translational Modification of This DT
Overview of CACNA1C Modification Sites with Functional and Structural Information
Sequence
MVNENTRMYI PEENHQGSNY GSPRPAHANM NANAAAGLAP EHIPTPGAAL SWQAAIDAAR 
QAKLMGSAGN ATISTVSSTQ RKRQQYGKPK KQGSTTATRP PRALLCLTLK NPIRRACISI 
VEWKPFEIII LLTIFANCVA LAIYIPFPED DSNATNSNLE RVEYLFLIIF TVEAFLKVIA 
YGLLFHPNAY LRNGWNLLDF IIVVVGLFSA ILEQATKADG ANALGGKGAG FDVKALRAFR 
VLRPLRLVSG VPSLQVVLNS IIKAMVPLLH IALLVLFVII IYAIIGLELF MGKMHKTCYN 
QEGIADVPAE DDPSPCALET GHGRQCQNGT VCKPGWDGPK HGITNFDNFA FAMLTVFQCI 
TMEGWTDVLY WVNDAVGRDW PWIYFVTLII IGSFFVLNLV LGVLSGEFSK EREKAKARGD 
FQKLREKQQL EEDLKGYLDW ITQAEDIDPE NEDEGMDEEK PRNMSMPTSE TESVNTENVA 
GGDIEGENCG ARLAHRISKS KFSRYWRRWN RFCRRKCRAA VKSNVFYWLV IFLVFLNTLT 
IASEHYNQPN WLTEVQDTAN KALLALFTAE MLLKMYSLGL QAYFVSLFNR FDCFVVCGGI 
LETILVETKI MSPLGISVLR CVRLLRIFKI TRYWNSLSNL VASLLNSVRS IASLLLLLFL 
FIIIFSLLGM QLFGGKFNFD EMQTRRSTFD NFPQSLLTVF QILTGEDWNS VMYDGIMAYG 
GPSFPGMLVC IYFIILFICG NYILLNVFLA IAVDNLADAE SLTSAQKEEE EEKERKKLAR 
TASPEKKQEL VEKPAVGESK EEKIELKSIT ADGESPPATK INMDDLQPNE NEDKSPYPNP 
ETTGEEDEEE PEMPVGPRPR PLSELHLKEK AVPMPEASAF FIFSSNNRFR LQCHRIVNDT 
IFTNLILFFI LLSSISLAAE DPVQHTSFRN HILFYFDIVF TTIFTIEIAL KILGNADYVF 
TSIFTLEIIL KMTAYGAFLH KGSFCRNYFN ILDLLVVSVS LISFGIQSSA INVVKILRVL 
RVLRPLRAIN RAKGLKHVVQ CVFVAIRTIG NIVIVTTLLQ FMFACIGVQL FKGKLYTCSD 
SSKQTEAECK GNYITYKDGE VDHPIIQPRS WENSKFDFDN VLAAMMALFT VSTFEGWPEL 
LYRSIDSHTE DKGPIYNYRV EISIFFIIYI IIIAFFMMNI FVGFVIVTFQ EQGEQEYKNC 
ELDKNQRQCV EYALKARPLR RYIPKNQHQY KVWYVVNSTY FEYLMFVLIL LNTICLAMQH 
YGQSCLFKIA MNILNMLFTG LFTVEMILKL IAFKPKGYFS DPWNVFDFLI VIGSIIDVIL 
SETNHYFCDA WNTFDALIVV GSIVDIAITE VNPAEHTQCS PSMNAEENSR ISITFFRLFR 
VMRLVKLLSR GEGIRTLLWT FIKSFQALPY VALLIVMLFF IYAVIGMQVF GKIALNDTTE 
INRNNNFQTF PQAVLLLFRC ATGEAWQDIM LACMPGKKCA PESEPSNSTE GETPCGSSFA 
VFYFISFYML CAFLIINLFV AVIMDNFDYL TRDWSILGPH HLDEFKRIWA EYDPEAKGRI 
KHLDVVTLLR RIQPPLGFGK LCPHRVACKR LVSMNMPLNS DGTVMFNATL FALVRTALRI 
KTEGNLEQAN EELRAIIKKI WKRTSMKLLD QVVPPAGDDE VTVGKFYATF LIQEYFRKFK 
KRKEQGLVGK PSQRNALSLQ AGLRTLHDIG PEIRRAISGD LTAEEELDKA MKEAVSAASE 
DDIFRRAGGL FGNHVSYYQS DGRSAFPQTF TTQRPLHINK AGSSQGDTES PSHEKLVDST 
FTPSSYSSTG SNANINNANN TALGRLPRPA GYPSTVSTVE GHGPPLSPAI RVQEVAWKLS 
SNRERHVPMC EDLELRRDSG SAGTQAHCLL LRKANPSRCH SRESQAAMAG QEETSQDETY 
EVKMNHDTEA CSEPSLLSTE MLSYQDDENR QLTLPEEDKR DIRQSPKRGF LRSASLGRRA 
SFHLECLKRQ KDRGGDISQK TVLPLHLVHH QALAVAGLSP LLQRSHSPAS FPRPFATPPA 
TPGSRGWPPQ PVPTLRLEGV ESSEKLNSSF PSIHCGSWAE TTPGGGGSSA ARRVRPVSLM 
VPSQAGAPGR QFHGSASSLV EAVLISEGLG QFAQDPKFIE VTTQELADAC DMTIEEMESA 
ADNILSGGAP QSPNGALLPF VNCRDAGQDR AGGEEDAGCV RARGRPSEEE LQDSRVYVSS 
L
PTM type
X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1C [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1683

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at CACNA1C Lysine 1683 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1C [2]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1690

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at CACNA1C Lysine 1690 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1C [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

153

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1C Asparagine 153 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1C [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

328

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1C Asparagine 328 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1C [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1436

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1C Asparagine 1436 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1C [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1487

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1C Asparagine 1487 has the potential to affect its expression or activity.

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1C [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1078

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at CACNA1C Cystine 1078 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1C [5]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

2183

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at CACNA1C Cystine 2183 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        19 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Enhancing the activity of CACNA1C [6]

Role of PTM

Protein Activity Modulation

Modified Residue

Serine

Modified Location

1981

Related Enzyme

cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)

Studied Phenotype

Diabetes mellitus [ICD11: 5A10-5A14]

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1981 have been reported to enhance its transport activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1C [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 260 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1C [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

465

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 465 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1C [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

815

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 815 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNA1C [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

863

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 863 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNA1C [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1645

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1645 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNA1C [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1692

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1692 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence CACNA1C [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1718

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1718 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence CACNA1C [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1736

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1736 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence CACNA1C [14] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1739

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1739 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence CACNA1C [16]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1760

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1760 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence CACNA1C [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1847

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1847 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence CACNA1C [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1860

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1860 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence CACNA1C [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1861

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1861 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence CACNA1C [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1904

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 1904 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence CACNA1C [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2069

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 2069 has the potential to affect its expression or activity.

  PTM Phenomenon 17

Have the potential to influence CACNA1C [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2072

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 2072 has the potential to affect its expression or activity.

  PTM Phenomenon 18

Have the potential to influence CACNA1C [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2077

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 2077 has the potential to affect its expression or activity.

  PTM Phenomenon 19

Have the potential to influence CACNA1C [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2098

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Serine 2098 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1C [20] , [21]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

171

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 171 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1C [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

468

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 468 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1C [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

476

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 476 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1C [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1130

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 1130 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNA1C [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1133

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 1133 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNA1C [18]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1919

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 1919 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNA1C [22]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1953

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 1953 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence CACNA1C [19]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2081

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Threonine 2081 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1C [23]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1920

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Tyrosine 1920 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1C [23]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

2217

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1C Tyrosine 2217 has the potential to affect its expression or activity.
References
1 Right gastroepiploic artery for coronary artery bypass grafting: a word of caution. Ann Thorac Surg. 2001 Dec;72(6):2184-5.
2 Diffusion imaging of the brain. J La State Med Soc. 2001 Nov;153(11):527-8.
3 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: CAC1C_HUMAN)
4 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
6 Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes. Sci Signal. 2017 Jan 24;10(463):eaaf9647.
7 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
9 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
10 Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.
11 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
12 Cyclic AMP-dependent protein kinase phosphorylates residues in the C-terminal domain of the cardiac L-type calcium channel alpha1 subunit. Biochim Biophys Acta. 1996 Jun 11;1281(2):205-12.
13 Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054.
14 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
15 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
16 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
17 Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells. Oncotarget. 2016 Sep 20;7(38):61229-61245.
18 Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
19 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
20 p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
21 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
22 Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H. Int J Mol Sci. 2015 Feb 16;16(2):4209-25.
23 COOH-terminal association of human smooth muscle calcium channel Ca(v)1.2b with Src kinase protein binding domains: effect of nitrotyrosylation. Am J Physiol Cell Physiol. 2007 Dec;293(6):C1983-90.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.